Inventor · disambiguated record
Bernd Riedl
Also filed as: RIEDL BERND
31 granted patents·47 pending applications·1,341 citations·filing 1992–2021
98Inventor score
Top patents by PatentIndex Score
78 records- 0197US8071616B2Pyridine, quinoline, and isoquinoline N-oxides as kinase inhibitorsDUMAS JACQUES·Filed 2010·Granted Dec 6, 2011·48 cites·19 claims
- 0297US7678811B2Pyridine, quinoline, and isoquinoline N-oxides as kinase inhibitorsBAYER HEALTHCARE LLC·Filed 2007·Granted Mar 16, 2010·57 cites·17 claims
- 0397US7235576B1Omega-carboxyaryl substituted diphenyl ureas as raf kinase inhibitorsBAYER PHARMACEUTICALS CORP·Filed 2002·Granted Jun 26, 2007·94 cites·47 claims
- 0496US7897623B2ω-carboxyl aryl substituted diphenyl ureas as p38 kinase inhibitorsBAYER HEALTHCARE LLC·Filed 2007·Granted Mar 1, 2011·35 cites·8 claims
- 0596US7528255B2Hydroxy, ω-carboxyaryl substituted diphenyl ureas and dirivatives thereof as raf kinase inhibitorsBAYER PHARMACEUTICALS CORP·Filed 2002·Granted May 5, 2009·35 cites·15 claims
- 0696US7351834B1ω-Carboxyaryl substituted diphenyl ureas as raf kinase inhibitorsBAYER PHARMACEUTICALS CORP·Filed 2000·Granted Apr 1, 2008·64 cites·41 claims
- 0796US5529998ABenzoxazolyl- and benzothiazolyloxazolidinonesBAYER AG·Filed 1995·Granted Jun 25, 1996·122 cites·6 claims
- 0895US5627181A6-membered nitrogen-containing heteroaryl-oxazolidinonesBAYER AG·Filed 1995·Granted May 6, 1997·87 cites·5 claims
- 0994US8841330B2Omega-carboxyaryl substituted diphenyl ureas as raf kinase inhibitorsRIEDL BERND·Filed 2012·Granted Sep 23, 2014·12 cites·14 claims
- 1094US5698574A5-membered heteroaryl-oxazolidinonesBAYER AG·Filed 1995·Granted Dec 16, 1997·84 cites·6 claims
- 1193US5827857APyrido-fused thienyl- and furanyl-oxazolidinonesBAYER AG·Filed 1997·Granted Oct 27, 1998·78 cites·8 claims
- 1292US8124630B2ω-carboxyaryl substituted diphenyl ureas as raf kinase inhibitorsRIEDL BERND·Filed 2001·Granted Feb 28, 2012·27 cites·16 claims
- 1392US6069160AHeteroatom-containing benzocyclopentane-oxazolidinonesBAYER AG·Filed 1996·Granted May 30, 2000·77 cites·8 claims
- 1491US7371763B2Inhibition of raf kinase using quinolyl, isoquinolyl or pyridyl ureasBAYER PHARMACEUTICALS CORP·Filed 2005·Granted May 13, 2008·17 cites·37 claims
- 1590US5792765ASubstituted oxazolidinonesBAYER AG·Filed 1997·Granted Aug 11, 1998·103 cites·9 claims
- 1689US5869659AHeteroatom-containing cyclopentanopyridyl-oxazolidinonesBAYER AG·Filed 1997·Granted Feb 9, 1999·85 cites·8 claims
- 1784US7928239B2Inhibition of RAF kinase using quinolyl, isoquinolyl or pyridyl ureasBAYER HEALTHCARE LLC·Filed 2001·Granted Apr 19, 2011·15 cites·18 claims
- 1884US5684023ABenzofuranyl -and benzothienyloxazolidinonesBAYER AG·Filed 1995·Granted Nov 4, 1997·68 cites·11 claims
- 1983US6589949B13-oxo-2,1-benzisoxazol-1(3H)-carboxamides for treatment of CNS diseasesBAYER AG·Filed 2000·Granted Jul 8, 2003·23 cites·10 claims
- 2083US5922708AHeteroaryl-oxazolidinonesBAYER AG·Filed 1997·Granted Jul 13, 1999·66 cites·11 claims
- 2183US5843967A6-membered nitrogen-containing heteroaryl-oxazolidinonesBAYER AG·Filed 1996·Granted Dec 1, 1998·48 cites·17 claims
- 2282US8637553B2Fluoro substituted omega-carboxyaryl diphenyl urea for the treatment and prevention of diseases and conditionsBOYER STEPHEN·Filed 2004·Granted Jan 28, 2014·15 cites·16 claims
- 2379US5861413A2-oxo- and 2-thio-1,2-dihydroquinolinyl-oxazolidinonesBAYER AG·Filed 1997·Granted Jan 19, 1999·51 cites·6 claims
- 2475US8318761B2Substituted arylsulfonamides as antiviral agentsSVENSTRUP NIELS·Filed 2008·Granted Nov 27, 2012·5 cites·8 claims
- 2574US9181188B2Aryl ureas as kinase inhibitorsDUMAS JACQUES·Filed 2012·Granted Nov 10, 2015·3 cites·28 claims
- 2673US8110587B2Aryl ureas as kinase inhibitorsDUMAS JACQUES·Filed 2003·Granted Feb 7, 2012·8 cites·39 claims
- 2765US2008032979A1Omega-Carboxyaryl Substituted Diphenyl Ureas As Raf Kinease InhibitorsRIEDL BERND·Filed 2007·Application pending·0 cites
- 2863US2008153823A1Omega-Carboxyaryl Substituted Diphenyl Ureas As Raf Kinase InhibitorsRIEDL BERND·Filed 2007·Application pending·0 cites
- 2961US2008300281A1Inhibition of p38 Kinase Activity Using Aryl and Heteroaryl Substituted Heterocyclic UreasDUMAS JACQUES·Filed 2008·Application pending·0 cites
- 3061US2009118268A1OMEGA-CARBOXY ARYL SUBSTITUTED DIPHENYL UREAS AS p38 KINASE INHIBITORSRIEDL BERND·Filed 2008·Application pending·0 cites
- 3160US8304406B2Compounds for treating pulmonary hypertensionKLEIN MARTINA·Filed 2007·Granted Nov 6, 2012·2 cites·18 claims
- 3259US2008194580A1Inhibition Of Raf Kinase Using Quinolyl, Isoquinolyl Or Pyridyl UreasDUMAS JACQUES·Filed 2007·Application pending·0 cites
- 3359US2007244120A1Inhibition of raf kinase using substituted heterocyclic ureasDUMAS JACQUES·Filed 2007·Application pending·0 cites
- 3457US2014329866A1Omega-carboxyarl substituted diphenyl ureas as raf kinase inhibitorsRIEDL BERND·Filed 2014·Application pending·0 cites
- 3557US2001027202A1Omega-carboxyaryl substituted disphenyl ureas as raf kinase inhibitorsFiled 2001·Application pending·0 cites
- 3655US2012046290A1Inhibition of p38 kinase activity using substituted heterocyclic ureasDUMAS JACQUES·Filed 2007·Application pending·0 cites
- 3755US2013131122A1Fluro substituted Omega-Carboxyaryl Diphenyl Urea for the Treatment and Prevention of Diseases and ConditionsBAYER HEALTHCARE LLC·Filed 2012·Application pending·0 cites
- 3853US2012129893A1Inhibition Of Raf Kinase Using Substituted Heterocyclic UreasDUMAS JACQUES·Filed 2012·Application pending·0 cites
- 3953US2003216396A1Pyridine, quinoline, and isoquinoline N-oxides as kinase inhibitorsBAYER AG·Filed 2003·Application pending·0 cites
- 4053US2008108672A1Omega-Carboxyaryl Substituted Diphenyl Ureas As Raf Kinase InhibitorsRIEDL BERND·Filed 2007·Application pending·0 cites
- 4152US5504189APeptides, their preparation and useBASF AG·Filed 1992·Granted Apr 2, 1996·9 cites·1 claims
- 4252US2008269265A1Inhibition Of Raf Kinase Using Symmetrical And Unsymmetrical Substituted Diphenyl UreasMILLER SCOTT·Filed 2008·Application pending·0 cites
- 4350US2001016659A1Omega-carboxyaryl substituted diphenyl ureas as raf kinase inhibitorsFiled 2001·Application pending·0 cites
- 4450US2003105091A1Omega-carboxy aryl substituted diphenyl ureas as p38 kinase inhibitorsFiled 2002·Application pending·0 cites
- 4550US2001034447A1Omega-carboxyaryl substituted diphenyl ureas as raf kinase inhibitorsFiled 2001·Application pending·0 cites
- 4650US2002042517A1Omega-carboxyaryl substituted diphenyl ureas as raf kinase inhibitorsBAYER AG·Filed 2001·Application pending·0 cites
- 4749US2001011135A1Omega-carboxyaryl subsituted diphenyl ureas as raf kinase inhibitorsFiled 2001·Application pending·0 cites
- 4849US2001011136A1omega-carboxyyaryl substituted diphenyl ureas as raf kinase inhibitorsFiled 2001·Application pending·0 cites
- 4948US2002137774A1Carboxyaryl substituted diphenyl ureas as raf kinase inhibitorsBAYER AG·Filed 2001·Application pending·0 cites
- 5048US2023303647A1Cyclic chemerin-9 derivativesBAYER AG·Filed 2021·Application pending·0 cites
Showing the top 50 of 78 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →